Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 82300 refers to a laboratory test specifically designed to measure the levels of cadmium in the body. Cadmium is classified as a transitional metal and is commonly found in various industrial settings, particularly in mining, smelting, and refining operations. Exposure to cadmium can occur through several routes, including inhalation of airborne particles, which is often a risk for workers in environments where cadmium is present. Additionally, individuals may be exposed to cadmium through smoking cigarettes, as tobacco plants can absorb cadmium from contaminated soil. Ingestion of food crops that have been grown in cadmium-contaminated soil or water is another potential source of exposure. Furthermore, cadmium can be absorbed through the skin, particularly from jewelry that contains high levels of this metal. Symptoms associated with cadmium exposure can vary widely and may include proteinuria (the presence of excess protein in urine), fever, headache, dyspnea (difficulty breathing), chest pain, sore throat, cough, conjunctivitis (inflammation of the eye), and rhinitis (inflammation of the nasal mucous membrane). In cases of cadmium toxicity, individuals may experience more severe symptoms such as vomiting, diarrhea, abdominal pain, and cramping. To conduct the test, a blood sample is collected, which is reported separately through a venipuncture procedure. Additionally, a urine sample is obtained, which can be collected either as a voided specimen or through catheterization, with options for random or 24-hour timed collection. The analysis of both blood and urine samples is performed using quantitative inductively coupled plasma-mass spectrometry, a highly sensitive technique that allows for accurate measurement of cadmium levels in biological samples.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test for cadmium measurement is indicated for individuals who may have been exposed to cadmium through various means. The following conditions and symptoms warrant the performance of this test:
The procedure for measuring cadmium levels involves several key steps to ensure accurate results. The first step is the collection of a blood sample, which is obtained through a venipuncture. This involves inserting a needle into a vein, typically in the arm, to draw blood into a collection tube. It is important that this procedure is performed by a trained healthcare professional to minimize discomfort and ensure proper technique. Following the blood collection, a urine sample is also required for the test. This can be obtained in two ways: either as a voided specimen, where the patient simply urinates into a collection container, or through catheterization, which involves inserting a catheter into the bladder to collect urine directly. The urine sample can be collected randomly or as a 24-hour timed collection, depending on the specific requirements of the test. Once both samples are collected, they are sent to a laboratory where they undergo analysis using quantitative inductively coupled plasma-mass spectrometry. This advanced testing method allows for precise measurement of cadmium levels in both blood and urine, providing critical information regarding the patient's exposure and potential toxicity.
After the cadmium testing procedure, patients may be advised to resume their normal activities unless otherwise directed by their healthcare provider. There are typically no specific post-procedure care instructions required for the blood draw or urine collection. However, patients should be informed about potential symptoms of cadmium exposure and toxicity, and they should seek medical attention if they experience any concerning symptoms following the test. The results of the cadmium test will be reviewed by a healthcare professional, who will discuss the findings and any necessary follow-up actions based on the levels detected in the samples.
| Short Descr | ASSAY OF CADMIUM | Medium Descr | CADMIUM | Long Descr | Cadmium | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | GA | Waiver of liability statement issued as required by payer policy, individual case | GW | Service not related to the hospice patient's terminal condition | GZ | Item or service expected to be denied as not reasonable and necessary | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit |
|
Date
|
Action
|
Notes
|
|---|---|---|
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.